|
|
|
|
| LEADER |
01000caa a2200265 4500 |
| 001 |
OLC198029464X |
| 003 |
DE-627 |
| 005 |
20230513005346.0 |
| 007 |
tu |
| 008 |
160816s2016 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a PQ20160815
|
| 035 |
|
|
|a (DE-627)OLC198029464X
|
| 035 |
|
|
|a (DE-599)GBVOLC198029464X
|
| 035 |
|
|
|a (PRQ)pubmed_primary_274809590
|
| 035 |
|
|
|a (KEY)0108894720160000076001504309commentaryonkrasmutationstatusispredictiveofrespon
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
4 |
|a 610
|q DNB
|
| 084 |
|
|
|a XA 10000
|q AVZ
|2 rvk
|
| 084 |
|
|
|a 44.81
|2 bkl
|
| 100 |
1 |
|
|a Benjamin, Laura E
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Commentary on "KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer"
|
| 264 |
|
1 |
|c 2016
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 773 |
0 |
8 |
|i Enthalten in
|t Cancer research
|d Birmingham, Ala. [u.a.] : AACR, 1941
|g 76(2016), 15, Seite 4309
|w (DE-627)12906775X
|w (DE-600)1432-1
|w (DE-576)014399199
|x 0008-5472
|7 nnns
|
| 773 |
1 |
8 |
|g volume:76
|g year:2016
|g number:15
|g pages:4309
|
| 856 |
4 |
2 |
|u http://www.ncbi.nlm.nih.gov/pubmed/27480959
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_OLC
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OLC-DE-84
|
| 912 |
|
|
|a GBV_ILN_55
|
| 912 |
|
|
|a GBV_ILN_62
|
| 912 |
|
|
|a GBV_ILN_69
|
| 912 |
|
|
|a GBV_ILN_2005
|
| 912 |
|
|
|a GBV_ILN_2219
|
| 912 |
|
|
|a GBV_ILN_4012
|
| 912 |
|
|
|a GBV_ILN_4219
|
| 936 |
r |
v |
|a XA 10000
|
| 936 |
b |
k |
|a 44.81
|q AVZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 76
|j 2016
|e 15
|h 4309
|
